JULIE SINGH
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism ENGLEWOOD CLIFFS, NJ NPI 1669912374
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NJ SANOFI-AVENTIS U.S. LLC All categories
This page merges CMS profile IDs: 7216559, 8789960 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$2,871.26
- Category: General Payments
- Program years: PY2019–2024
- Record count: 124
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,608.61 across 75 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,608.61 | 75 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $381.59 | 9 |
| Lilly USA, LLC | $304.22 | 21 |
| Amgen Inc. | $246.19 | 9 |
| ABBVIE INC. | $113.48 | 7 |
| Novo Nordisk AS | $93.96 | 5 |
| Medtronic, Inc. | $92.96 | 2 |
| Insulet Corporation | $42.31 | 2 |
| IBSA Pharma Inc. | $32.46 | 2 |
| TOLMAR, INC. | $30.45 | 2 |
| Xeris Pharmaceuticals, Inc. | $28.56 | 2 |
| Aurinia Pharma U.S., Inc. | $23.80 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.34 | 1 |
| DEXCOM, INC. | $17.65 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.37 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $16.71 | 1 |
| Kyowa Kirin, Inc. | $16.53 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.30 | 1 |
| Radius Health, Inc. | $16.19 | 1 |
| Currax Pharmaceuticals LLC | $16.18 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.08 | 1 |
| Kiniksa Pharmaceuticals International, plc | $16.07 | 1 |
| MannKind Corporation | $15.96 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.73 | 1 |
| Janssen Biotech, Inc. | $15.52 | 1 |
By program year
Records — PY2024 (75)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 7216559, 8789960
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.